alexa
Reach Us +44-7482-864460
Onco-Plus: An Integrated Database And Computational Protocol For Discovery Of Lead Molecules Targeting Unique DNA | 86540
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Onco-Plus: an integrated database and computational protocol for discovery of lead molecules targeting unique DNA

Joint Event on 10th International Conference on Genomics and Molecular Biology & 6th International Conference on Integrative Biology

Akhilesh Mishra, Pradeep Pant and B Jayaram

IIT Delhi, India

Posters & Accepted Abstracts: J Mol Genet Med

DOI: 10.4172/1747-0862-C2-028

Abstract
The specific binding of transcription factors (TFs) to specific DNA sequences make the DNA motifs promising drug targets for the coordinated regulation of gene expression. Here, we present Onco-Plus, an integrated database of regulatory motifs of cancer genes clubbed with Unique Sequence Predictor (USP) (http://www.scfbio-iitd.res.in/software/onco/NavSite/index. htm) and a software suite for targeting DNA for drug discovery. USP identifies unique sequences (i.e. these sequences occur only once in the entire genome and if targeted would presumably show no off-target binding /side effects) for each of the identified regulatory DNA motifs at the specified position in the genome by extending a given DNA motif, in 5’→3’or 3’→5’ or in both directions. For each identified motif, three possible unique sequences could be generated. Taking off from the identified unique sequences as drug targets, a rapid virtual screening against a million-compound library could be performed (http:// www.scfbio-iitd.res.in/PSDDF/tool4.php) to generate a list of hit molecules (potential candidate drugs) with their predicted binding free energies. This methodology is demonstrated on E2F transcription factor binding site for the WNT10B gene, implicated in breast and endometrial cancers and a few small molecules are proposed as potential drug candidates. Being fast and cost effective, this protocol could be of considerable value in generating new potential drug candidates to inhibit desired sequences for further experimental studies.
Biography

Akhilesh Mishra has done his Master’s in Bioinformatics from Jamia Millia Islamia, New Delhi, India. He is pursuing his PhD from Indian Institute of Technology, New Delhi. He is the Recipient of CSIR-UGC-SRF and BINC award from the Department of Biotechnology, India. He has published many research articles in reputed peer reviewed journals.
Email:[email protected]

Top